For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Similar documents
GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Familial Adenomatous Polyposis

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

The Genetics of Familial Polyposis

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

GI Polyp syndromes in children. Screening and surveillance, surgery.

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

CANCER GENETICS PROVIDER SURVEY

Classification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

Disclosure. Polyps in Pediatrics. Learning Objectives. Case Presentation I. Case Presentation II

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Hereditary GI tumor syndromes ACG guidelines of genetic testing and management. Dr. med. Henrik Csaba Horváth PhD

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

YES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)

Hereditary Gastric Cancer

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

12: BOWEL CANCER IN FAMILIES

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Primary Care Approach to Genetic Cancer Syndromes

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

GI EMERGENCIES Acute Abdominal Pain

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

LIST OF ABBREVIATIONS

Resident Seminar Aug 19 th, 2015 Colon: Neoplastic. Scott Rieder Dr. Colquhoun

Management of higher risk of colorectal cancer. Huw Thomas

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

What All of Us Should Know About Cancer and Genetics

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER. Dr Abhijit Dixit. Family Health Clinical Genetics

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Michele Bettinelli RN Maria Scholz RN Sandra Scolaro RN

Colorectal Cancer Syndromes. Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago

Risk Assessment and Risk Management

Colonic Polyp. Najmeh Aletaha. MD

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

FAMILIAL ADENOMATOUS POLYPOSIS (COLORECTAL CANCER) PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

Duodenal adenomas Management. Dr Stratis Alexandridis Consultant Gastroenterologist BRI

Gastrointestinal polyposis syndromes for the general gastroenterologist

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

Hereditary Cancer Update: What do GPOs need to know?

EARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

Hereditary Colorectal Cancer

General Surgery Grand Grounds

2012 update. Bowel Cancer. Information for people at increased risk of bowel cancer. Published by the New Zealand Guidelines Group

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

An Introduction to MUTYH Associated Polyposis (MAP)

GI Screening/Surveillance in Lynch Syndrome

Epi procolon 2.0 CE is a blood test for colorectal cancer screening.

Clinical Genetics Service

GUIDELINES FOR THE USE OF GENOGRAMS IN PALLIATIVE CARE

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

David P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Update from the 2011 symposium: MOH testing criteria

Prior Authorization. Additional Information:

Lori Carpenter, MS, LCGC Saint Francis Hospital

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Colorectal Cancer and Hereditary Colon Cancer Syndromes Carol A. Burke, M.D.

Dr Marion Harris (Medical Oncologist)

The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes 1. Lynch Syndrome

Inherited colon cancer and other inherited cancer predispositions. Dr Anne De Leener Centre de Génétique Humaine

Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Serrated Polyps and a Classification of Colorectal Cancer

Genetic testing all you need to know

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

COLORECTAL CARCINOMA

Genetic Testing for Lynch Syndrome


GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

FREQUENTLY ASKED QUESTIONS

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Advice about familial aspects of breast cancer and epithelial ovarian cancer

ACG Clinical Guideline: Colorectal Cancer Screening

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Information for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer

Endoscopic techniques for surveillance and treatment of FAP

Transcription:

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions South Island Cancer Nurses Network September 2013

Who are we? Specialist multidisciplinary team: Nurse coordinators, gastroenterologists, geneticists, colorectal surgeons, oncologists. National service: Branches in Auckland, Wellington and Christchurch. What do we do? Assess GI cancer risk on basis of family history. Facilitate diagnosis of hereditary cancer syndromes by confirming family history. Facilitate genetic testing. Surveillance recommendations. Co-ordinate surveillance for high risk families.

Referrals GP, Specialist, Genetic service, self referrals Accepted if meet potential high risk guidelines

Risk of inherited bowel cancer 95-98% of population: Average population risk: No personal or family history CRC; OR Slightly above average: 1 o relative over 55 years. 2-5% of the population: Moderately increased risk. 1 st degree relative under 55 or two 1 st degree relatives with CRC at any age (on same side of family). 1% - potentially high risk. 3 or more relatives with CRC over 2 generations with 1 aged <50 at diagnosis HNPCC or FAP

Risk factors for CRC are both environmental and inherited. Sporadic disease No family history. Accounts approx 70 %. Common over the age of 50. Dietary & environmental factors. Familial Up to 25% of cases. Family history of CRC. Pattern is not consistent with one of the inherited syndromes. Individuals from these families are at increased risk of developing CRC. Risk is not as high as with the inherited syndromes. Inherited Fewer than 10% a true inherited predisposition CRC subdivided. Associated with a high risk of developing CRC. Often the causative genetic mutation has been identified and can be tested for.

Family History of Bowel Cancer Individuals with a family history of CRC have an increased risk of developing the disease. The risk depends on the number of relatives affected, degree of relationship and their age at diagnosis. To assess familial risk for CRC need a family history. Should include any CRC in 1st or 2nd degree relative on either side of the family, over three generations if possible. 1 st Degree relatives: parents, siblings, children. 2 nd Degree relatives: grandparents, aunts, uncles, nieces, nephews. CRC reported in relatives should be confirmed if possible.

Hereditary CRC syndromes are as rare as hens teeth! It is NEVER simple working up the family confirming the diagnosis But knowing alters management reassures impacts the whole family & next generation

What makes us suspicious it s inherited? Cancer occurs at unusually young age compared with usual presentation. Development of multiple tumours in a single organ. Development of more than one primary tumour of any type. Family history of cancer of the same or a related type in firstdegree relatives. High rate of cancer occurrence in the family.

Hereditary Diffuse Gastric Ca Peutz-Jeghers Cowdens FAP HNPCC MYH polyposis hyperplastic polyposis Juvenile Polyposis Peutz-Jeghers Cowdens

HNPCC- Hereditary Non Polyposis Colorectal Cancer Lynch Syndrome

HNPCC Mutations (Ref 4)

Management & surveillance Gastrointestinal Increased frequency of colonoscopy. Gastroscopy also in some families.? Colectomy. Extracolonic No definitive evidence that it s effective.

Familial Adenomatous Polyposis FAP

Familial Adenomatous Polyposis (FAP) Colonic adenomatous polyps 100 s to 1000 s. Polyps always become cancerous if left untreated. Caused by a germline mutation in APC gene. Possible duodenal polyposis Autosomal dominant inheritance-50/50 chance. Affects both sexes. World wide.

In addition to CRC patients with FAP are at risk for several extracolonic malignancies including: Duodenal ampullary carcinoma. Follicular or papillary thyroid cancer. Childhood hepatoblastoma. Gastric carcinoma. CNS tumors (mostly medulloblastomas). Desmoids.

Management Once colonic polyposis is established in a gene carrier or an at-risk member of an FAP family: Full colonoscopy to evaluate the extent of the colonic polyposis. Initial upper GI endoscopy. Consultation arranged to discuss the timing of a colectomy. Number, size, and worst histology of the colonic adenomas determine the optimal timing of colectomy.

FAP continued: Without timely surgical intervention inevitably develop colorectal carcinoma by the age of 40-50 years. Polyposis typically develops in the second or third decade of life. Mean age was 16 years. Most patients are operated on between age 15 and 25.

Ongoing surveillance Endoscopy with side viewer frequency calculated on Spigelman criteria. Follow up after rectal surgery of remaining bowel usually yearly depending on adenoma burden.

Conclusion Please refer to NZFGCS if patient has: Self or 1 st degree relative diagnosed CRC under 50y One 1st plus two or more 2 nd degree rels with CRC on same side of family diagnosed any age Two 1 st or one 1 st and one or more 2 nd degree rels with CRC on same side family with one under 55y, or one with multiple CRCs or one also with extra colonic HNPCC related cancer One 1 st or 2 nd degree rel with CRC and multiple polyps Family history of HNPCC, FAP or other CRC syndrome

Thank you!